Biohaven Pharmaceutical Holding Return on Investment 2016-2022 | BHVN
Current and historical return on investment (ROI) values for Biohaven Pharmaceutical Holding (BHVN) over the last 10 years.
| Biohaven Pharmaceutical Holding ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2022-03-31 |
$-0.52B |
$0.17B |
2050.98% |
| 2021-12-31 |
$-0.71B |
$-0.12B |
1018.05% |
| 2021-09-30 |
$-0.72B |
$0.03B |
1005.59% |
| 2021-06-30 |
$-0.74B |
$-0.18B |
1124.24% |
| 2021-03-31 |
$-0.73B |
$-0.01B |
3565.85% |
| 2020-12-31 |
$-0.65B |
$-0.13B |
3445.33% |
| 2020-09-30 |
$-0.61B |
$0.05B |
-4880.00% |
| 2020-06-30 |
$-0.54B |
|
inf% |
| 2020-03-31 |
$-0.58B |
|
inf% |
| 2019-12-31 |
$-0.48B |
|
inf% |
| 2019-09-30 |
$-0.39B |
|
inf% |
| 2019-06-30 |
$-0.36B |
|
inf% |
| 2019-03-31 |
$-0.20B |
|
inf% |
| 2018-12-31 |
$-0.22B |
|
inf% |
| 2018-09-30 |
$-0.20B |
|
inf% |
| 2018-06-30 |
$-0.19B |
|
inf% |
| 2018-03-31 |
$-0.18B |
|
inf% |
| 2017-12-31 |
$-0.11B |
|
-2038.10% |
| 2017-09-30 |
$-0.10B |
|
-2040.00% |
| 2017-06-30 |
$-0.09B |
|
-1800.00% |
| 2017-03-31 |
$-0.07B |
$0.02B |
-1440.00% |
| 2016-12-31 |
$-0.06B |
$-0.00B |
24400.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.248B |
$0.463B |
|
Biohaven Pharmaceutical is a commercial-stage biotechnology company focused on developing, and commercializing products, primarily in the fields of central nervous system diseases, including neurological and rare disorders.
|
